Literature DB >> 11786122

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

Nilufer Broeders, Daniel Abramowicz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786122     DOI: 10.1046/j.1523-1755.2002.00129.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  Screening and Identification of Differentially Expressed and Adipose Growth-Related Protein-Coding Genes During the Deposition of Perirenal Adipose Tissue in Rabbits.

Authors:  Guoze Wang; Kun Du; Zhenjian Xie; Renyong Tang; Xianbo Jia; Shiyi Chen; Songjia Lai
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-01       Impact factor: 3.168

2.  Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.

Authors:  Hao Pan; Kezhen Shen; Xueping Wang; Hongzhou Meng; Chaojun Wang; Baiye Jin
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

3.  Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ.

Authors:  Zhi-Hao Zhang; Jun-Qiu He; Ying-Yong Zhao; Hua-Chao Chen; Ning-Hua Tan
Journal:  Acta Pharmacol Sin       Date:  2019-11-08       Impact factor: 6.150

Review 4.  Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease.

Authors:  Tieshan Teng; Shuai Qiu; Yiming Zhao; Siyuan Zhao; Dequan Sun; Lingzhu Hou; Yihang Li; Ke Zhou; Xixi Yu; Changyong Yang; Yanzhang Li
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

5.  PPARgamma in Kidney Physiology and Pathophysiology.

Authors:  Eva Kiss-Tóth; Tamás Roszer
Journal:  PPAR Res       Date:  2009-03-10       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.